Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.64
Bid: 41.48
Ask: 41.54
Change: 0.74 (1.81%)
Spread: 0.06 (0.145%)
Open: 42.08
High: 42.08
Low: 41.20
Prev. Close: 40.90
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Jul 2020 07:00

RNS Number : 1660S
Assura PLC
07 July 2020
 

7 July 2020

Assura plc

 

Trading Update

For the first quarter ending 30 June 2020

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter ending 30 June 2020.

 

Jonathan Murphy, CEO, said:

"We've had an active first quarter, as we continued to deliver strategic and financial progress across all areas of the business, despite these uncertain times for the UK. Our business model remains resilient and robust, as demonstrated by normal patterns of recent rent collections and all our development sites being active in line with social distancing guidelines.

"Our social purpose - to create outstanding primary care properties that sit at the heart of our local communities - has never been more important than it is today, and we are making good progress with our recently launched sixbysix social impact strategy.

"As lockdown restrictions gradually ease, we are working closely with our GP partners to ensure we best support the NHS and respond to evolving market needs as part of the 'new normal'. Primary care will play a crucial role as the UK seeks to rebuild and recover from the COVID-19 crisis and we are engaging with Government to ensure that it remains a key area of investment going forward."

 

Operational update

· Safety and wellbeing of our colleagues, tenants and patients our top priority

· Ongoing discussions with our tenants and the NHS on how our buildings can best support the evolving needs of GPs and patients as we gradually move out of the lockdown

· All construction sites active with appropriate social distancing measures in place

· June quarter rents being received in line with normal patterns

 

Active first quarter

· Strong portfolio of 565 properties with current annualised rent roll of £110.2 million

· Developments at Stafford and Netherfield completed (combined cost £11.9 million) - the latter is on track for a BREEAM rating of "Excellent", incorporating a number of sustainable elements including electric vehicle charging points, photovoltaic panels and an air source heat pump

· Five schemes progressed to on-site, including Stourport in Worcestershire which is part funded by NHS England's Estates and Technology Transformation Fund ("ETTF")

· Seven acquisitions completed for combined £35 million

· Portfolio of 20 assets disposed for £17 million, as disclosed in our year end results in May

· Two lease regears completed (£0.3 million of existing rent)

· One capital asset enhancement project completed and three currently on site (combined spend £0.6 million)

 

Strong pipeline for growth

· Currently on-site with 18 developments with a total cost of £95 million

· Immediate development pipeline totalling £60 million: schemes which we expect to be on site within 12 months

· Immediate acquisitions pipeline stands at £51 million, which we would normally expect to complete in three-six months

· 45 lease re-gears covering £5.6 million of existing rent roll in the current pipeline

· Pipeline of 21 capital asset enhancement projects (projected spend £15 million) over the next two years

 

Robust balance sheet

· At 30 June 2020 gross debt stood at £767 million with undrawn facilities of £300 million

· As announced with our year end results in May, the maturity of the revolving credit facility has been extended to November 2025, with the facility reducing from £300 million to £225 million with effect from May 2021

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 680

Email: Investor@assura.co.uk

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

Email: Assura@Finsbury.com

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFESDDIRIII
Date   Source Headline
1st May 20242:30 pmRNSHolding(s) in Company
1st May 20247:00 amRNSNotice of Year End Results
30th Apr 20247:00 amRNSTotal Voting Rights
16th Apr 20247:40 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSScrip Dividend Declaration
22nd Mar 20242:18 pmRNSHolding(s) in Company
14th Mar 20248:30 amRNSScrip Calculation Price
6th Mar 20241:26 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSNotice of Dividend
8th Feb 20242:00 pmRNSCapital Markets Event
7th Feb 20242:33 pmRNSDirector/PDMR Shareholding
1st Feb 20249:32 amRNSTotal Voting Rights
16th Jan 20248:26 amRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
9th Jan 20248:59 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSScrip Dividend Declaration
21st Dec 20234:20 pmRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSScrip Calculation Price
6th Dec 20232:57 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSNotice of Dividend
16th Nov 20237:00 amRNSAssura Plc Interim Results
8th Nov 20232:32 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSAppointment of Board Fellow
31st Oct 20237:00 amRNSNotice of Interim Results
31st Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20232:04 pmRNSDirector/PDMR Shareholding
9th Oct 202311:13 amRNSDirector/PDMR Shareholding
9th Oct 20238:11 amRNSScrip Dividend Declaration
9th Oct 20237:00 amRNSRefinancing of RCF & new sustainability linkage
9th Oct 20237:00 amRNSTrading Update
18th Sep 20239:51 amRNSVesting and sale of restricted shares
14th Sep 20239:20 amRNSScrip Calculation Price
31st Aug 20237:00 amRNSNotice of Dividend
24th Aug 20238:36 amRNSHolding(s) in Company
8th Aug 20235:05 pmRNSDirector/PDMR Shareholding
31st Jul 20239:57 amRNSTotal Voting Rights
24th Jul 20237:00 amRNSDevelopment update
14th Jul 20231:47 pmRNSDirector/PDMR Shareholding
13th Jul 20234:47 pmRNSExercise of Nil Cost Options under PSP
12th Jul 20234:36 pmRNSDirector/PDMR Shareholding
10th Jul 202312:38 pmRNSHolding(s) in Company
10th Jul 20239:20 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSScrip Dividend Declaration & Additional Listing
6th Jul 20232:47 pmRNSResult of AGM
6th Jul 202312:28 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSTrading Update
3rd Jul 20237:00 amRNSChange of Registered Office
29th Jun 20234:46 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSCompletion of 100th development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.